Literature DB >> 8810822

Intrauterine programming of hypertension: nutrient-hormone interactions.

S Langley-Evans1, A Jackson.   

Abstract

Geographic, retrospective, and prospective epidemiologic studies have revealed evidence that the environment in utero is a major determinant of later degenerative disease. Observations from Britain, Sweden, Jamaica, Australia, India, and China support the hypothesis that disproportionate retardation of fetal growth results in increased blood pressure and increased risk of cardiovascular mortality. On the basis of what has been a limited pool of observations linking maternal undernutrition and fetal growth retardation, it has been proposed that hypertension and coronary heart disease are "programmed" by nutrition status.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8810822     DOI: 10.1111/j.1753-4887.1996.tb03923.x

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  4 in total

1.  Fetal and infant origins of adult disease.

Authors:  C N Hales
Journal:  J Clin Pathol       Date:  1997-05       Impact factor: 3.411

2.  The impact of maternal protein restriction during rat pregnancy upon renal expression of angiotensin receptors and vasopressin-related aquaporins.

Authors:  Ruth Cornock; Simon C Langley-Evans; Ali Mobasheri; Sarah McMullen
Journal:  Reprod Biol Endocrinol       Date:  2010-08-31       Impact factor: 5.211

3.  Effects of lead exposure before pregnancy and dietary calcium during pregnancy on fetal development and lead accumulation.

Authors:  S Han; D H Pfizenmaier; E Garcia; M L Eguez; M Ling; F W Kemp; J D Bogden
Journal:  Environ Health Perspect       Date:  2000-06       Impact factor: 9.031

Review 4.  The Role of the Paraventricular-Coerulear Network on the Programming of Hypertension by Prenatal Undernutrition.

Authors:  Bernardita Cayupe; Blanca Troncoso; Carlos Morgan; Patricio Sáez-Briones; Ramón Sotomayor-Zárate; Luis Constandil; Alejandro Hernández; Eugenia Morselli; Rafael Barra
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.